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4 Neural Cell Adhesion Molecule 
NCAM in Neural and Endocrine 
Cells 
Keith Langley and Manfred Gratzl 
4.1 The Concept of Cell Type Markers 
Considerable interest has centered over the last twenty years on the search for 
methods permit t ing the distinction between different cell types in complex 
tissues. Whi le classical histological staining methods have proved invaluable in 
studying the cellular architecture of tissues, the search for more specific 
techniques that afford unambiguous identification of cell types was motivated 
by the fact that purely histological criteria frequently prove inadequate in other 
than normal adult tissues. I n immature and in pathological tissues the 
microscopical appearance of cells is often radically different from that found in 
the healthy adult. In addition, increasing use of isolated cells grown in tissue 
culture has prompted the use of criteria other than those based on cellular 
morphology, which is rarely identical to that of the in vivo counterparts of 
cultivated cells and which may, moreover, be influenced by tissue culture 
conditions. 
Al though considerable progress towards this goal has been achieved by the 
development of histochemical methods, the major recent advances have 
followed the introduction and widespread application of immunocytochemical 
technology. This has dramatically altered both the way we recognize cells and 
indeed even the way in which we define a given cell type. Thus in the 
pre-immunocytochemical era cells were originally defined by their anatomical 
location and cellular morphology, which were correlated to their putative 
function. For example, silver impregnation methods have previously been very 
successfully employed to illustrate the delicate arborizations of large cerebellar 
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neurons (Ramon y Cajal, 1905; Palay and Chan-Palay, 1974); in addition such 
staining methods suggested the function of such neurons in terms of their 
multiple synaptic connections wi th other cerebellar neurons. Current use of 
immunocytochemical methods performs the same task more easily and in a 
much more consistent manner (Mikoshiba et a l . , 1979; Reeber et a l . , 1981; 
Langley et a l . , 1982b; Lohmann et al . , 1981; Roth et a l . , 1981). Similarly, 
astrocytes, which had early been visualized by Golgi methods as satellite cells 
wi th end-feet on blood vessels, may now be easily distinguished by the use of 
antibodies to the protein GFAP (Gl ia l Fibri l lary Acidic Protein) considered to 
be specific for these cells (Dahl and Bignami, 1973; Eng and Bigbee, 1978). 
Such technology has led to a redefinition of astrocytes as cells which contain 
GFAP. 
This specificity of expression of certain proteins by certain cell types forms 
the basis of current use of immunocytochemistry to identify cell types (for 
review see Langley et a l . , 1984). The precise mechanisms that lead to such 
specificity of expression of certain proteins are not yet clear. However i t is 
evident that, while the genetic information contained in the cell nucleus after 
fertilization is potentially capable of coding for all proteins expressed by all cell 
types present in the adult organism, during embryogenesis regulatory mechan-
isms predispose the expression of certain of these proteins and determine the 
suppression of others. Pathological processes may nevertheless alter the 
normal course of events, resulting in up or down regulation of individual 
proteins in response to external st imuli . Moreover, cells in tissue culture have 
been shown to respond to external factors, including growth factors and 
hormones, by altered expression of "cell specific" proteins (e.g. Doherty and 
Walsh, 1987; Grant et a l . , 1988). However the mature normal cell may be 
defined as one in which the expression of a number of biochemical character-
istics has reached a stable state. Thus, a given cell type which was previously 
defined only by morphological criteria may now be accorded a biochemical 
definition in terms of the range of proteins, glycoproteins and lipids expressed. 
While a large number of proteins are found to be present in many quite 
different cell types in the animal kingdom, a l imited number may be expected 
to be associated wi th the specific nature or function of a given type and thus 
have a more restricted cellular distribution. This property of cell specificity of 
such molecules permits their use as marker substances to distinguish between 
different cell types. The value of these molecules as cell-type markers depends 
on their capacity to be expressed by a cell in both normal and abnormal 
(pathological or in culture) situations which may vary for certain proteins. This 
is particularly important when choosing a marker protein as a diagnostic tool in 
clinical practice. The elegance and precision of cell labeling methods have 
outweighed such minor disadvantages and have totally altered pathological 
laboratory practice for clinical diagnosis over recent years. 
4.2 The NCAM Family 135 
A second aspect of cell marker proteins should not be forgotten. I t is 
reasonable to suppose that the exclusive or predominant expression of a given 
protein by a given cell type may be associated wi th the particular biological or 
physiological function of that cell. Dur ing the seventies the search for neuron 
specific proteins was prompted by the conviction that such proteins would be 
intimately associated wi th brain function. This is clearly the case for the 
enzymes involved in specific neurotransmitter metabolism or for the neuro-
transmitters themselves (for review see Langley et a l . , 1984). Extensive 
neuropeptide mapping studies have indeed taught us a great deal about how the 
brain functions (Hökfe l t et a l . , 1980).The l ink between cell marker protein and 
function is less evident in many other cases such as for example the S-100 
protein (Malus and Mughal , 1975), the function of which remains a mystery 
long after the ini t ia l demonstration of its cellular specificity. 
This chapter w i l l concentrate principally on aspects of cellular expression but 
also briefly mention the likely function of what has been more recently revealed 
to be a family of related glycoproteins, collectively recognized under the name 
of neural cell adhesion molecule N C A M . 
4.2 The NCAM Family 
I n order to better understand the cellular distribution of the different N C A M 
proteins, a brief historical account of their discovery and what is currently 
known of their biochemistry and molecular biology w i l l be given.The discovery 
of this family of marker proteins was motivated by the search for molecules 
implicated in the construction of the extraordinary complexity of central 
nervous tissue.The adult human brain contains more than 10 8 neurons, each of 
which forms many synaptic connections. Such connections are not formed 
randomly but appear to follow overall design principles that lead to very 
specific inerconnecting patterns. The molecular mechanisms by which neurons 
select their target cells to produce such selective networks have intrigued 
neurobiologists for decades. 
Three independent laboratories in two different continents applied different 
experimental approaches in different animal models to address this question. 
Over a relatively short period of t ime, each published reports on "brain specific 
molecules" which were subsequently found to have associated cell adhesive 
properties. Thus, Gerald Edelmann group in New York used an experimental 
paradigm, modified from that used in earlier searches for adhesion molecules, 
to select molecules involved in the reaggregation of dissociated chick retinal 
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cells (for reviews see Edelman, 1983, 1984a,b; Rutishauser, 1984). He 
succeeded in isolating and purifying a molecule involved in such neural cell 
aggregation and referred to it as neural cell adhesion molecule. I t was soon 
realized that this molecule was the chick equivalent of a molecule previously 
identified by crossed-electrophoresis by Elizabeth Bock's group in Copenhagen 
from rat brain, called D2 (J0rgensen and Bock, 1974; J0rgensen et a l . , 1980). 
This was one of several brainspecific proteins identified by this group at that 
time (Bock et a l . , 1975). Curiously, amongst these figured a molecule called 
synaptin, which was the first description of the vesicle marker protein now 
called synaptophysin (see chapter 2) . A th i rd laboratory, Christo Goridis ' 
group in Marseille, using monoclonal antibody technology introduced in the 
1970's obtained an antibody recognizing a brain cell surface protein, BSP-2, in 
the mouse ( H i r n et a l . , 1981) which was subsequently shown to be the mouse 
equivalent of N C A M and D2 (Faissner et a l . , 1984; Noble et a l . , 1985). 
The different data obtained on these three sets of molecules can thus now be 
collated to build up a more complete picture of the characteristics of what has 
been agreed since 1985 to be the same antigen, for which the name N C A M 
originally given by Edelman has been adopted. Since independant studies had 
been performed on what were originally considered to be unrelated molecules a 
number of ini t ia l contradictions appear when comparing the early literature on 
N C A M , D2 and BSP-2; for example whether or not glial cells express this 
molecule. While many of these differences no longer appear to exist certain 
species differences regarding the N C A M polypeptide forms expressed are 
evident; these wi l l be discussed in more detail below. From the vast literature on 
N C A M several basic characteristics of this family can be singled out. 
A unique gene coding for N C A M , containing nineteen principal exons, is 
present in the haploid genome. A mechanism of alternative splicing is currently 
considered (Rutishauser and Goridis, 1986; Owens et al . , 1987; Goridis and 
Wi l l e , 1988) to give rise to several species of m R N A the number of which varies 
according to species. I n the chicken brain three N C A M m R N A species of 7.4, 
6.7 and 4.3 have been detected and are thought to be translated into three 
principal N C A M polypeptides wi th molecular masses of approximately 180, 
140 and 120 (referred to here as N C A M 180, N C A M 140 and N C A M 120, 
equivalent to N C A M large domain N C A M small domain and N C A M small 
surface domain) (Cunningham et a l . , 1987). The two larger forms contain a 
single transmembrane region and differ essentially in the lengths of their 
cytoplasmic domains (Cunningham, 1986; Cunningham et a l . , 1987; Gennarini 
et a l . , 1984a,b; Nybroe et a l . , 1985; Bartheis et a l . , 1987; Santoni et a l . , 1987), 
while the smaller isoform is anchored to the membrane by the intermediary of a 
phosphatidylinositol residue (He et a l . , 1987).The sequences external to the 
cell membrane of all three forms are essentially identical, containing five 
regions similar to those present in immunoglobulins (Bartheis et a l . , 1987; 
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Cunningham et al . , 1987; Will iams, 1987), which has led to the classification of 
the N C A M gene as a member of the immunoglobulin super gene family. The 
homophilic binding site, in addition to a heparin binding site and a "hinge" 
region, are situated in the external domain of the molecule (Cole et al . , 
1986a,b; Cole and Glaser, 1986; Cole and Akeson, 1989; Freiinger and 
Rutishauser, 1986; Becker et al . , 1989). 
The situation appears to be rather more complex in rodents since in both the 
mouse (Gennarini et al . , 1986; Barbas et a l . , 1988) and the rat (Small et al . , 
1987) five N C A M m R N A species are detectable of 7.4, 6.7, 5.2,4.3 and 2.9 kb , 
two of which seem to encode for N C A M 120 (5.2 and 2.9 kb) . These two 
m R N A s differ in the size of their noncoding regions, a first polyadenylation 
signal being used to generate the 2.9 kb m R N A and a second signal 2.3 kb 
downstream being used for the 5.2 kb message (Goridis and Wi l l e , 1988; 
Bartheis et a l . , 1987). By analogy wi th the chicken the 7.4 kb m R N A is 
considered to code for N C A M 180. 
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Fig. 4-1 Schematic representation of the NCAM gene, its transcription by alternative 
splicing and translation into the three principal NCAM polypeptides, illustrating the 
position of the sequences coded by different exons relative to the plasma membrane, the 
immunoglobulin-like domains and sites (arrowheads) of additional (tissue-specific) 
"minor" exons and their coded sequences. 
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O f the 19 major exons in the N C A M c D N A exons 1—14 are used to generate 
the external sequences of all three polypeptides, exon 15 codes for the 
anchoring sequence of N C A M 120 and exon 18 codes for the additional 
cytoplasmic 30-40 k D insert unique to N C A M 180 (Fig. 4.1 and Murray et a l . , 
1986; Owens et a l . , 1987; Nybroe et a l . , 1988). Recently additional exons in the 
N C A M gene have been discovered, some of which code for large sequences in 
N C A M isoforms in certain tissues. Thus muscle N C A M m R N A contains an 
exon situated between exons 12 and 13 called msd (muscle specific domain) 
encoding a 37 amino acid sequence unique to this tissue (Walsh, 1988). Smaller 
additional exons have been found in rodent brain N C A M c D N A (Santoni et a l . , 
1989). I n particular exon π (30 bases) situated between exons 7 and 8 codes for 
a region in one of the immunoglobulin like domains, that may be close to the 
homophilic binding site and thus modify binding affinity (Santoni et a l . , 1989). 
Two more exons, one o f only three base pairs, the other of 15, both situated 
between exons 12 and 13 code for a sequence in the hinge region of the 
molecule. These additional exons can give rise to minor heterogeneities in the 
three principal N C A M translation products, which may be fairly difficult to 
detect on immunoblots, since the molecular weights may differ very l i t t le f rom 
those of the principal forms. However S I nuclease protection assays provide 
clearcut evidence of the existence in brain of mult iple forms of m R N A coding 
for these additional polypeptides.Theoretically 24 different m R N A species are 
possible giving rise to 18 different N C A M polypeptides (Santoni et a l . , 
1989). 
The molecules are modified post-translationally by phosphorylation, sulpha-
t ion and glycosylation (Lyles et a l . , 1984a; Nybroe et a l . , 1988). Glycosylation 
has been particularly well studied since major changes in levels of sialylation 
occur during normal brain development. Early so-called embryonic forms of 
N C A M contain high levels of polysialic acid groups, which markedly influences 
the adhesive binding properties of the molecule (Edelman, 1984; Rutishauser 
et a l . , 1985, 1988). N C A M isolated from adult tissue contains much less sialic 
acid. I n addition to changes in polysialic acid, subsets of N C A M contain 
another carbohydrate hapten, H N K - 1 , consisting of 3'sulfated glucuronic acid 
(Noronha et a l . , 1986) recognized by antibodies first isolated as recognizing 
human natural kil ler cells (Schuller-Petrovic et a l . , 1983; Kruse et a l . , 1984). 
Thus, in summary, although three principal size classes of N C A M polypeptides 
have been found in both nervous and other tissues, all N C A M molecules of the 
same size class are not identical. Some may contain additional aminoacid 
sequences, others may be modified post-translationally in slightly different 
ways either containing different levels of polysialylation or different carbohy­
drate haptens (Will iams et a l . , 1985). 
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4.3 Cellular Distribution of NCAM 
4.3.1 Methodological Approaches 
Two basic approaches have been employed to address the question of cellular 
N C A M expression; these may be broadly classified as morphological or 
biochemical. 
4.3.1.1 Immunocytochemistry 
The introduction by Coons et al. in 1941 of the use of flourescent probes 
covalently bound to antibodies and later modifications (Coons, 1961) provided 
the first opportunity of directly visualizing given protein tissue constituents at a 
cellular level. Considerable technical progress in immunocytochemical 
methods has subsequently eliminated many of the drawbacks of the early 
techniques and has led to the use of such methods as routine highly sensitive 
and specific staining procedures in pathological laboratories. Many techniques 
are currently available which differ in the probe or in the number of antibodies 
employed to visualize the molecule of interest. A l l depend for their success on 
the quality of the primary antibody i.e. its specificity and affinity for the antigen 
in question (Swaab et a l . , 1977). The higher the affinity of the antibody, the 
more it can be usefully diluted: the greater the d i lu t ion , the lower background 
non-specific staining w i l l be, and thus the higher the specificity of the staining 
pattern. 
This chapter w i l l not attempt to review the advantages of individual 
methods. However it is important to remember that technical differences alone 
may give rise to apparently conflicting observations from different laboratories. 
In particular, the absence of staining may be simply due to the use of 
monoclonal antibodies wi th relatively lower affinities than commonly found 
wi th polyclonal antibodies. In addition monoclonal antibodies are sometimes 
more sensitive to tissue fixation procedures. Particular care should also be 
exercised wi th certain monoclonal antibodies that recognize cytoplasmic 
epitopes of N C A M , since cell permeabilization is a necessary prerequisite for 
their use. 
O f the probes currently employed, fluorescent molecules such as fluores-
ceine isothiocyanate or rhodamine, or enzymes giving permanent preparations, 
such as peroxidase or alkaline phosphatase, have proved valuable for light 
microscopy. A t the ultrastructural level peroxidase has proved to be the most 
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versatile. Colloidal gold particles bound either to secondary antibodies or to 
protein A (Langley and Aunis , 1986; van den Pol et a l . , 1986) are particularly 
useful for labeling surface of antigens of isolated or cultured cells when 
morphometric analysis can be performed, but are l imi ted by penetration 
problems when employed on ρ re-embedding tissue sections. The lack of 
penetration into ultrathin sections has l imited the routine exploitat ion of 
post-embedding immunogold methods for N C A M localization. 
4.3.1.2 Biochemical Approaches 
Valuable information on cellular expression of individual N C A M glycoproteins 
has been obtained wi th combined immunochemical and protein separation 
techniques, which has only been partially possible wi th immunocytochemistry 
since antibodies specifically recognizing each of the three N C A M isoforms are 
not available. I n particular turnover studies have been performed on N C A M 
isolated by immunoprecipitation followed by gel electrophoresis of extracts 
from cells labeled wi th radioactive precursors ( H i r n et a l . , 1983; Lyles et a l . , 
1984b; Nybroe et a l . , 1986; Linneman et a l . , 1985). More commonly 
electrophoresis and immunostaining of Western blots proves to be simpler and 
adequate for analyzing different N C A M isoforms in different tissues (Rougon 
e ta l . , 1982; Hoffman et a l . , 1986; Nagata and Schachner, 1986). Quanti ta t ion is 
possible when radioiodinated second antibodies or protein A are used to locate 
the protein bands. The technique of crossed-electrophoresis (Bock, 1972) and 
E L I S A have also provided quantitative estimates of different N C A M isoforms 
(Bock et a l . , 1983).These methods have been usefully applied in biosynthetic 
studies of N C A M in cultured neurons, glial cells and tumor lines. In vivo studies 
on N C A M extracted from the lateral geniculate nucleus after injection of 
radioactive precursors into the eye (which is followed by axonal transport of 
newly synthesized glycoproteins along the optic nerve) has afforded compari­
sons wi th the in vitro situation (Nybroe et a l . , 1986). Cell free translation of 
N C A M has also been investigated using crude R N A preparations f rom cultured 
cells and tissue homogenates (Nybroe et a l . , 1986). 
Post-translational modifications have also been studied by immunochemical 
techniques. The most important of these as already mentioned concerns 
polysialic acid (PSA) content in the so-called embryonic form and is of special 
interest in pathology where frequently these forms reappear. Thus after nerve 
injury newly synthesized N C A M is found to be highly sialylated which is 
probably related to the need for less stability in intercellular contacts during the 
period of cellular redistribution and tissue repair (Dani loff et a l . , 1986a). The 
presence of high PSA forms of N C A M can be easily suspected f rom Western 
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immunoblots by their appearance as broad diffuse bands of higher apparent M r 
(200-250 k D ) . Pretreatment of such forms of N C A M wi th neuraminidase, 
which removes successive sialic acid residues from PSA chains, alters their 
anomalous electrophoretic profile from a broad smear to the descrete three 
banded pattern of adult brain N C A M (Rutishauser, 1984). This suggests that 
the three principle N C A M isoforms are present during embryonic life but are 
polysialylated. 
Other post-translational modifications affecting the external domain of 
N C A M have been studied. Sub-populations of N C A M polypeptides may be 
distinguished by their complement of carbohydrate epitopes. The H N K - 1 
carbohydrate present on human natural ki l ler cells ( A b o and Balch, 1981) has 
been detected by successive immunoprecipitat ion wi th different antibodies on 
various adhesion molecules including L I , M A G and N C A M (Kruse et a l . , 1984; 
1985; Poltorak et a l . , 1987). Only about 30 % of N C A M isolated from rodent 
brain carry this epitope. I t has been suggested that this carbohydrate may itself 
be a ligand in cell adhesion ( K ü n e m u n d et a l . , 1988). 
4.3.1.3 Hybridizat ion Techniques 
Since the isolation of clones of total or partial N C A M c D N A and their 
subsequent sequencing it has become feasable to examine the expression of the 
N C A M message either at a cellular level by the technique of in situ 
hybridization (where a specific oligonucleotide probe or a probe derived from a 
partial c D N A is hybridized to tissue sections) or in tissue R N A extracts by 
either Northern blots or S i nuclease protection assays. This is a particularly 
important development since such approaches not only confirm the capacity of 
a cell to synthesize N C A M , but also provide valuable information on its 
regulation at the genetic level. Such approaches are complementary to studies 
employing antibodies, since in one case the message is detected while in the 
other its translation product, the localization of which is not always identical 
(Prieto et al . , 1989). Furthermore the technique of S I nuclease protection 
analysis provides information on the sequence of the bases in the N C A M 
m R N A as well as the precise nature of the exons present (Bartheis et a l . , 1987; 
Santoni et a l . , 1989). However, in cells or tissues where N C A M turnover is slow 
it may prove much more difficult to detect low levels of the m R N A , while 
significant levels of N C A M peptides pose no problems for visualization wi th 
antibodies. 
U p to the present time few reports of in situ hybridization studies have been 
published but, in contrast, m R N A analytical studies of tissue extracts are 
numerous (Covault et a l . , 1986; Murray et a l . , 1986; Gennarini et a l . , 1986) and 
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have provided very interesting data on developmental changes. Most early 
studies on N C A M distribution concentrated on embryonic development where 
the greatest changes in expression may be expected to occur in parallel w i th 
important tissue induction events. I n this section we w i l l concentrate mainly on 
N C A M expression in different cell types of adult tissues, where the phenotype is 
stable, before discussing some of the early modifications, which are frequently 




One of the earliest references to a molecule that was subsequently found to be 
equivalent to N C A M was published in a report of a search for brain specific 
antigens (J0rgensen and Bock, 1974; Bocket a l . , 1974; 1975; Bock et a l . , 1980). 
Fig. 4-2 Vibratome section of adult rat cerebellum immunoperoxidase labeled for 
NCAM. 
Note the intense staining of the molecular layer, the unstained cytoplasm of Purkinje 
cells and marked staining of granule cells. Bar = 20 am. 
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Fig. 4-3 Electron micrograph of rat cerebellar granule cells labeled for NCAM. 
The plasma membranes are intensely stained and cytoplasm is weakly immunoreactive. 
Section not counterstained. Bar = 1 μιτι. 
The D2 antigen detected amongst several others, including protein 14-3-2 
equivalent to neuron specific enolase was found to be absent from cultured 
astrocytes but enriched in synaptosomal fractions of rat brain. Though this 
antigen appeared not to be l imited to nerve terminals a neuronal origin was 
concluded. A t the same time, while much of the early work of Edelmanns group 
concentrated on embryonic tissues, this group published direct immunocyto-
chemical evidence of N C A M expression over the entire surface of mature 
sympathetic neurons, even though these were isolated from late embryonic 
chicks (Rutishauser et a l . , 1978a), wi th an antibody previously found to be 
capable of inhibit ing embryonic retinal cell aggregation (Brackenbury et a l . , 
1977; Rutishauser et al . , 1978b). In contrast, a much more topographically 
restricted expression has been reported both in the retina (J0rgensen and 
Möller , 1981) and also in cerebellum where it was considered to be confined to 
synaptic regions of the neuronal membrane (J0rgensen and Möller , 1980). 
Later studies in both rodents and chickens provided convincing evidence of the 
widespread expression of N C A M by all types of neurons in vivo over their 
entire surface (see Figs. 4-2 and 4-3; Langley et a l . , 1982a, 1983; Dani loff et a l . , 
1986b; Chuong et al . , 1987). Such discrepancies are probably the result of 
differences in the affinity of antibodies used in different laboratories and also in 
different tissue fixation procedures. Immunoelectron microscopy did however 
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reveal interesting differences between different types of cerebellar neurons 
(Langley et a l . , 1982a; 1983). N C A M was detected in granule cells, which 
constitute numerically the vast majority of cerebellar neurons, intracellularly in 
the perikaryon, although l i t t le was detected in their axons, in addition to at 
their cell surface. A n intracellular localization was never observed for the large 
cerebellar neurons such as Purkinje cells, presumably because cytoplasmic 
levels were below limits of detection. These data were interpreted as reflecting 
differences of N C A M transport or turnover in different types of neurons. The 
question of turnover rates of N C A M in neurons of adult tissues is an intr iguing 
one, which has been addressed in the biosynthetic studies of Elizabeth Bock's 
group, which reported that N C A M turnover was extremely slow in adult tissue. 
I n fact it was calculated to decrease 350 fold during development (Linnemann 
et a l . , 1985). This would suggest that once N C A M is transported to the cell 
surface of Purkinje cells or to the distant parallel fibres (axons) of granule cells 
in normal adult cerebellum, it is subject to very slow degradation, resynthesis 
and reinsertion in the membrane. I n contrast, synthesis of N C A M and transport 
through the Golgi apparatus to the cell membrane has been shown to be a rapid 
phenomenon in cultured neurons, lasting only several minutes (Lyles et a l . , 
1984a). These data explain the absence or relatively low levels of N C A M 
observed immunocytochemically in the cytoplasm compared wi th the neuronal 
cell membrane. Though in healthy adult nervous tissue the N C A M synthetic 
machinery appears to be relatively silent, i t is evident that external influences 
which may be provoked by traumatism can rapidly stimulate synthesis 
(Daniloff et a l . , 1986a). More recent immunocytochemical studies (Dani loff et 
al . , 1986b) have confirmed that the adult N C A M staining pattern of chick 
nervous system reflects that of the late embryo (Thiery et a l . , 1982; Crossin et 
al . , 1985) except for a diminut ion in intensity. This reduced N C A M immuno-
labeling in adult tissue is particularly str iking in myelinated fibre tracts such as 
spinal cord and optic nerve. Some reports suggest that the down-regulation of 
N C A M during development leads to its complete suppression in mature 
myelinated axons (Mirsky et a l . , 1986; Mar t in i and Schachner, 1988). As 
already pointed out, caution in interpreting negative immunocytochemical 
data should be exercised since the detection of low antigen levels is much more 
dependant on technical factors. Nevertheless down regulation is confirmed by 
comparative analysis of both N C A M protein and N C A M m R N A levels in 
adults and young animals (Bock et a l . , 1980; Linnemann et a l . , 1985; Nybroe et 
al . , 1986; Gennarini et a l . , 1986). I t is l ikely that it is sti l l present even on axons 
of CNS and PNS neurons in the adult though at much reduced levels and may 
also be associated wi th a slower turnover. I n addition the reduced expression of 
N C A M in adult peripheral nerves seems also to be associated w i t h changes in its 
topographical distribution on the axon surface: the membrane at nodes of 
Ranvier appear to contain more N C A M than is detectable on the internodal 
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axon (Rieger et al . , 1986). These highly specialized regions which predispose 
the rapid saltatory conduction of impulses in myelinated nerves were shown 
several years previously (Langley, 1979) to be the sites of high concentrations of 
acidic carboxylated polyanions (which could in part include sialic acid 
containing glycoproteins such as N C A M ) . Histochemistry wi th ruthenium red 
(a former botanical stain for pectin, a carboxyl acid rich polyanion) results in 
staining not only of the nodal axon membrane, but also the membrane of 
Schwann cells, which have subsequently been shown to contain N C A M (see 
below) . 
N C A M has also been shown to be present intraaxonally at nodes of Ranvier 
(Riegeret a l . , 1986), though the function associated wi th such a distribution at 
present remains obscure. Thus, in nervous tissues, a degree of compartmen-
talisation of N C A M expression may occur in vivo after permanent stable 
intercellular relationships are established. I n contrast, studies on neurons in 
vitro (Negre-Aminou et a l . , 1988) show no differences in total N C A M 
membrane density between cell bodies and neurite l ike extensions. This 
parallels the situation in vivo for non-myelinated fibres and may reflect a lesser 
degree of differentiation. 
4.3.2.2 N C A M Isoforms in Neurons 
I n surveying the literature on the nature of N C A M polypeptides expressed by 
neurons the reader is confronted by apparent contradictions. Many studies 
have been performed on neuronal cultures and it is often difficult to extrapolate 
from cultures to adult neurons for several reasons. Cell isolation and culture 
conditions may be expected to modify N C A M synthesis since this has been 
shown to be sensitive to traumatism influencing cell contact relationships in 
vivo. Trophic factors may at least be partly responsible for such changes 
(Prentice et al . , 1987). In addition most in vitro studies have employed neurons 
from embryonic tissues in which the stable adult N C A M phenotype has not 
been attained. 
I t is important first to consider species differences in the relative expression 
of individual N C A M polypeptides. Birds appear to express all three N C A M 
forms but their relative amounts and developmental pattern are different from 
those of rodents. The small surface domain peptide N C A M 120 is very weakly 
expressed in embryonic chick brain (Cunningham, 1986) compared to that of 
rodents and then only in late development. Contradictory data on frog N C A M 
has been published. I n one report (Sunshine et a l . , 1987) only N C A M 180 was 
detected while Levi et al. (1987) reported that N C A M 140 was the first 
detectable form early during embryogenesis followed by N C A M 180. The 
appearance of N C A M 120 was shown to be a relatively late developmental 
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event as in the chicken. Frog is unusual however in the expression by liver of an 
N C A M of 160 k D different to the brain isoforms (Lev i et a l . , 1987). 
Analysis of tissue extracts from different anatomical regions of the CNS at 
different developmental times have led to conclusions on cell type expression of 
different N C A M isoforms (Rougon et a l . , 1982; Chuong and Edelman, 1984). 
Different brain regions reflect both developmental biosynthetic trends in 
different compartments of a given cell type as well as the cellular composition of 
the tissue at a given t ime. Since glial cells also contain N C A M , though in lower 
amounts, tissue extracts correspond to a mixture of both neuronal and glial 
components. Dur ing CNS development neuronal proliferation and migration in 
general preceed glial cell mult ipl icat ion and maturation. Thus total tissue 
N C A M at later stages w i l l reflect a relatively greater contr ibut ion f rom glial 
cells compared to neurons. I t has been found in general that N C A M 120 levels 
increase later than those of the other principal isoforms in developing brain. 
Analysis of adult spinal cord white matter demonstrates clearly that anatomical 
regional differences can give strong clues concerning cell type N C A M 
expression. Spinal cord contains relatively low amounts of N C A M 180 and 140 
and larger amounts of N C A M 120 (Chuong and Edelman, 1984). Its N C A M 
composition may provide a better indication of astrocyte N C A M isoforms than 
neuronal forms, since this tissue is composed mainly of axons and glial cells and 
both axonal and oligodendrocyte N C A M is repressed when fibres are 
myelinated. Both sets of data suggest that both N C A M 180 and 140 are more 
typically neuronal than N C A M 120. The use of antibodies that specifically 
recognize N C A M 180 in immunocytochemical studies of the cerebellum 
indicates that this polypeptide is characteristic of post-mitotic neurons 
(Pollerberg et a l . , 1985) and suggests that this polypeptide is topographically 
compartmentalized. Higher concentrations of N C A M were found to exist at 
contact sites between cells and it may be enriched on cell extensions (Pollerberg 
et al . , 1985; 1986). A t the present time it would be unwise to generalize from 
these findings, even though in a quite different model, reinforcement of 
neuronal character which is accompanied by neurite outgrowth is also 
paralleled by higher N C A M 180 R N A levels and increased N C A M 180 
synthesis (Doherty et a l . , 1988). 
The capacity of mature neurons in situ to synthesize and axonally transport 
all three N C A M forms has been demonstrated for retinal ganglion neurons 
(Nybroe et al . , 1986) and this agrees w i t h data showing in vitro translation of all 
N C A M forms wi th cerebellar granule cells microsomes ( i . e. post-mitotic 
neurons). Some reported immunochemical data of peripheral ganglia culture 
extracts also suggest that all three forms can be synthesized although 
N C A M 120 was minor, while other studies failed to detect N C A M 120 (Noble et 
a l . , 1985; Lyles et a l . , 1984a,b; Keilhauer et a l . , 1985; Nybroe et a l . , 1985). 
Such cultured cells may more closely resemble immature neurons. 
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4.3.2.3 "Embryonic" N C A M in Neurons 
Recent immunocytochemical data have demonstrated the persistance of the 
carbohydrate polymer of "embryonic" N C A M wi th an antibody against the 
unusual highly sialylated N C A M (Rougon et a l . , 1986) in isolated regions of 
adult rat brain (Aaron and Chesselet, 1989; Rougon et a l . , 1990) in contrast to 
the widely held opinion that the embryonic-adult conversion is complete before 
adulthood. 30 % of adult frog CNS N C A M is in the highly sialylated form 
(Sunshine et a l . , 1987). Regions where high levels of PSA persist may be 
associated wi th the need for greater plasticity of neuronal contacts, which is 
afforded by the lower adhesive affinity of highly sialylated forms (Rutishauser 
et a l . , 1988). The relative immaturi ty of cultured neurons isolated from 
embryonic or young animals even when maintained in culture for prolonged 
periods is illustrated by the fact that the conversion to adult forms of N C A M is 
rarely observed (Negre-Aminou et a l . , 1988), emphasizing the danger of 
extrapolating from cultures to adult tissues. Sialylation has been studied in 
acellular systems using lysates obtained from young and adult rats: sialylation 
of both N C A M 180 and 120 was observed with cerebellar granule cells, but the 
N C A M 140 isoform did not appear to be sialylated in vitro (Breen et al . , 1987, 
see also Schlosshauer, 1989). 
4.3.3 Astrocytes 
The first report showing that astrocytes in situ express N C A M were made wi th 
monoclonal antibodies against BSP-2, before it was realized that this antigen 
was equivalent to N C A M (Langley et al . , 1982a; H i r n et a l . , 1983). Whi le 
clearcut evidence of immunolabeling was obtained on cerebellar tissue 
sections, curiously the same antibodies failed to immunolabel cultured 
astrocytes. This may have been due to the relative immaturi ty of cultured 
astrocytes compared with their in situ counterparts, the relatively low levels of 
astrocyte N C A M compared to neurons and the relatively low affinity of the 
monoclonal antibodies employed at that time. More recent immunocytochem-
ical data wi th polyclonal antibodies (Noble et a l . , 1985) showed that cultured 
astrocytes indeed contain N C A M but quantitative analysis of immunolabeled 
cultured astrocytes (van den Pol et a l . , 1986) showed that membrane density 
was 25 fold less than that found on cultured (immature) neurons. Nevertheless, 
considerable variation in N C A M density was noted in neurons of the same 
culture. Immunoblot analysis of cultured astrocytes (Nybroe et a l . , 1986; Noble 
et a l . , 1985)showed a predominance of N C A M 140 wi th lower levels of N C A M 
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120, wi th li t t le or no detectable N C A M 180. As suggested above for neurons, 
cell type characteristic N C A M isoforms can be deduced from total N C A M 
extracts from anatomical regions consisting mainly of one type of cell 
expressing N C A M . Optic nerve and spinal cord myelinated tracts contain no 
nerve cell bodies, axon levels of N C A M are relatively low in the adult and 
oligodendrocytes in vivo do not appear to express significant quantities of 
N C A M . Thus the relatively high levels of N C A M 120 and low levels of N C A M 
180 found in adult rat spinal cord and optic nerve (our unpublished data) may 
be assumed to be mainly due to astrocytes. This agrees wi th the data f rom 
cultured astrocytes, but it may be argued that astrocytes in culture resemble 
"reactive" astrocytes. 
Further indications that N C A M 120 is a predominant N C A M translation 
product in astrocytes are obtained from studies of mixed neuronal and astrocyte 
cultures of Friedlander et al. (1985) in which N C A M 120 synthesis was found to 
be preferentially inhibited compared to other isoforms by inhibitors of cell 
proliferation which affect mainly astrocytes in these cultures. 
Pituicytes are the glial cells present in the neurohypophysis. While some 
morphological differences are notable between these cells and brain astrocytes, 
they resemble the latter wi th regard to the presence of G F A protein. 
Immunoelectron microscopy demonstrates that these cells, like brain astro-
cytes, also express N C A M (Fig. 4-5 and Langley et a l . , 1989a). Neurohypo-
physis has been found to contain l i t t le N C A M 120 (Langley et a l . , 1989a); it is 
possible that all is contributed by the pituicytes or that these cells have a 
different N C A M polypeptide phenotype than brain astrocytes. 
Section of peripheral nerve (Dani lof f et a l . , 1986a) or optic nerve (our 
unpublished data) produce a marked up-regulation of N C A M synthesis which 
in peripheral nerve is associated wi th a return to immature forms of N C A M . I n 
optic nerve the massive astrogliosis associated wi th axonal degeneration is 
accompanied by a considerable increase in immunostaining intensity w i th 
a n t i - N C A M antibodies. 
4.3.4 Oligodendrocytes 
In contrast to astrocytes, no direct immunocytochemical evidence in situ has 
been obtained of N C A M in oligodendrocytes, the other major brain glial cell 
type. Nevertheless the capacity of cultured oligodendrocytes to synthesize 
N C A M has been unambiguously demonstrated (Trotter et a l . , 1989; Bhat and 
Silberberg, 1985, 1988), which once more emphasizes the danger of extrapo-
lating from cultures to brain tissue. The profile of N C A M polypeptides 
expressed by cultured oligodendrocytes has been found to depend on their 
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degree of maturation. Oligodendrocyte maturation has been followed both in 
vivo and in vitro by the successive appearance of the glycolipid antigens 04 and 
01 (Trotter et a l . , 1989). Using these indices it was shown that immature 
oligodendrocytes express both N C A M 140 and 120 while more mature cells 
express predominantly N C A M 120. I n addit ion the N C A M in these cultures is 
highly polysialated demonstrating the relative immaturi ty of these cells. In vivo 
it is l ikely that the reduction of N C A M expression noted in culture continues 
further unt i l it is almost completely or total ly repressed by the t ime myelination 
occurs. 
4.3.5 Schwann Cells 
Even though Schwann cells are the peripheral nervous system myelinating 
counterparts of oligodendrocytes, marked differences exist between them. 
Oligodendrocytes can myelinate many axons, while the Schwann cell can 
myelinate a single internode. Schwann cells are surrounded by a basement 
membrane in situ and their embryonic origin is the neural crest, while 
oligodendrocytes like astrocytes are derived from neural tube precursor cells. 
Curiously, Schwann cells express proteins such as S-100 which in the CNS has 
been employed as an astrocyte marker. Schwann cells l ike both oligodendro-
cytes and astrocytes have been shown to express N C A M in culture, but like the 
latter continue to express it in vivo in normal adult tissues. I n addit ion, levels of 
N C A M in cultured Schwann cells are influenced by interactions w i th neurons 
(Seilheimer et al . , 1989). In vivo immunolabeling is intense when Schwann cells 
surround unmyelinated fibres, but i t has been reported that myelinating 
Schwann cells no longer contain N C A M (Mirsky et a l . , 1986; Covault and 
Sanes, 1986). I t is likely that down regulation occurs but low levels appear to 
persist in peripheral nerves at nodes of Ranvier (Rieger et a l . , 1986). 
Interestingly, the H N K - 1 epitope has also been localized at these sites in optic 
nerve (Ffrench-Constant et a l . , 1986). A s is the case wi th other neural crest 
derivatives, the principal isoform present in Schwann cells is N C A M 140. In 
crushed or sectioned peripheral nerves N C A M synthesis dramatically increases 
and embryonic forms reappear (Dani loff et a l . , 1986a). Part of this increase is 
probably contributed by Schwann cells. 
4.3.6 Endocrine Cells 
The diffuse endocrine system encompasses a wide dispersity of either isolated 
cells or cell collectives situated in anatomically distant regions of the body. Cells 
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of this system differ radically in terms o f the nature of their secretory products 
and their physiological function, but their classification as a common series is 
due to data, accumulated over several years, demonstrating many shared 
features.These include their general secretory nature (endocrine not exocrine), 
certain morphological characteristics ( in particular the presence of dense cored 
secretory granules visible in the electron microscope) and a number of 
biochemical parameters (see also chapter 1). Pearse (1968) was the originator 
of the concept of classifying neuroendocrine cells in a single series called 
A P U D cells (amine precursor uptake and decarboxylation). A n alternative 
terminology of neuroendocrine cells as paraneurons highlights similarities but 
also certain differences between them and neurons (Fujita, 1977). Certain 
endocrine cell types have been widely used as models for the study of secretory 
mechanisms, and as we have seen in chapter 2, parallels may exist w i th 
mechanisms regulating secretion at synapses in the central nervous system. 
Since the original A P U D classification was proposed for these cells, data 
obtained wi th experimental approaches unavailable at that t ime have con-
firmed the common presence of "marker" proteins in different cell types of this 
series, which is one of the principal motivations behind this book. The 
multiplici ty of common features of A P U D cells led Pearse (1969) to suggest 
that all had a common embryonic (neural crest) or igin. Subsequent advances in 
transplantation techniques have afforded the possibility of verifying this 
hypothesis. I t has frequently been confirmed: chromaffin cells of the adrenal 
medulla may thus be viewed as modified neural crest derived sympathetic 
neurons in which certain neuronal characteristics such as neurite formation and 
neurofilament and synapsin expression are suppressed. I n addit ion, the origin 
of the adenohypohysis, classically taught in medical schools to derive from the 
ectoderm of the stomodeum (primit ive mouth) , has been shown to have a 
neural origin, since cells destined to form this endocrine tissue are found in the 
neural ridge at early embryonic stages, but migrate away before formation of 
the neural crest (Couly and Le Douar in , 1985, 1987).Thus future hypophyseal 
cells may be subject to neural inductive influences before their arrival in the 
epithelial layer of the roof of the stomodeum. Notable exceptions to this 
hypothesis do however exist. The same elegant transplantation techniques 
demonstrating the neural origin of hypophysis have failed to confirm a similar 
origin for the pancreatic islet endocrine cells which are derived from cells 
situated in the ducts (see chapter 1; Le Douar in , 1978; Teitelman et a l . , 1987; 
Teitelman and Lee, 1987; Pearse, 1983). 
4.3.6.1 Immunocytochemistry 
The existence of certain common properties between neurons and neuroen-
docrine cells prompted us several years ago to investigate whether the same 
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adhesive mechanisms between cells operate in brain and the endocrine system. 
The presence of N C A M was first tested in adrenal medullary cells wi th their 
confirmed neural crest origin (Langley and Aunis, 1984) and later extended to a 
wider range of endocrine tissues, including those of non-neural origin and 
tumor cells (Langley et al . , 1987, 1989a). 
The presence of N C A M in chromaffin cells of the adrenal medulla has been 
demonstrated or confirmed by light microscopy by several laboratories 
(J0rgensen and Richter-Landsberg, 1983) and biosynthetic studies show it to be 
Fig. 4-4 Vibratome section of rat hypophysis immunoperoxidase labeled for 
NCAM. 
Note the very intense staining of the neural lobe (top), the discrete surface labeling of 
cells in the intermediate lobe (middle) and the moderate surface labeling of anterior 
lobe cells (bottom). Bar = 20 μπι. 
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Fig. 4-5 Electron micrograph of rat neurohypophysis immunostained for N C A M . 
illustrating the surface staining of a pituicyte surrounded by neurosecretory cell, 
granule-containing, terminal swellings, which are also labeled on their surface. Section 
not counterstained. Bar = 1 μιη. 
synthesized in cultured rat chromaffin cells (Nybroe et a l . , 1986). Ultrastruc-
tural studies unequivocally show its membrane localization on both endocrine 
cell types (both adrenergic and noradrenergic) in this tissue. Li t t le or no 
immunoreaction product has been detected intracellularly, which as for 
Purkinje cells in the cerebellum, may be the consequence of combined rapid 
transport and insertion into the plasmalemma after synthesis and a relatively 
slow turnover rate. Precise values on absolute amounts of N C A M in adrenal 
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medulla are not available but in the adult rat, levels are much lower than in 
cerebellum (unpublished observations). Some of this is present on both 
unmyelinated nerve fibres and the Schwann cells surrounding them. 
When other endocrine tissues were examined including the three lobes of the 
pituitary gland, the pancreas, tumor cell lines (Langley et a l . , 1989a) and 
certain human tumors (see below), an identical surface localization of N C A M 
was found immunocytochemically (Figs. 4-4-4-7). However, both qualitative 
and quantitative differences between different endocrine tissues have been 
found. For instance, in addition to the pronounced surface labeling of secretory 
cell processes, terminal swellings and nerve terminals constituting the neuroen­
docrine elements of the neurohypophysis, extracellular staining was observed 
using polyclonal a n t i - N C A M antibodies (Langley et al . , 1989a). Extracellular 
localization of this molecule has also been reported in muscle (Sanes et a l . , 
1986; Rieger et a l . , 1988). Since N C A M contains a heparin binding site (Cole 
and Glaser, 1986; Cole et a l . , 1986a,b) w i th a relative high affinity (Nybroe et 
a l . , 1989) capable of binding it to collagen fibrils by the intermediary of laminin, 
it is reasonable to suppose that any N C A M lost f rom the cell surface would 
adhere to neighbouring basement membrane components. Wether the loss of 
NCAM. 
The surface labeling of all cells in the islet contrasts with the absence of staining in the 
exocrine pancreas. Bar = 20 μιη. 
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Fig. 4-7 Electron micrograph of rat endocrine pancreatic cells immunostained for 
NCAM. 
The immunoreaction is confined to the plasma membranes. Section not counterstained. 
Bar = 1 iim. 
N C A M from cell surfaces is a normal phenomenon in healthy tissue is not 
known though a soluble secreted form of N C A M wi th a M r 120 k D has been 
shown to exist (Bock et a l . , 1987). However, levels of N C A M 120 are very low in 
the neurohypophysis and at the present t ime the molecular nature of N C A M 
found extracellularly has not been resolved. 
One of the striking features of the immunstaining pattern of rat pi tui tary 
gland sections concerns variations in labeling intensity found between the three 
lobes constituting this tissue (Fig. 4-4). The neural lobe is the most heavily 
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stained and the anterior lobe is moderately labeled, while intermediate lobe 
endocrine cells appear very discretely labeled at their surface (Langley et a l . , 
1989a). Apparent differences of intensity of immunolabeling should always be 
treated w i t h caution in immunocytochemistry. Similar differences were how-
ever observed on immunoblots when extracts from identical amounts of adeno-
and neurohypophysis were compared. I t is, however, difficult to evaluate 
whether such overall differences in tissue concentrations reflect real differences 
in N C A M membrane densities in the two lobes, since their cellular composition 
differ radically: the anterior lobe of the hypophysis consists essentially of 
aggregates of cell bodies wi th few cell processes while the neurohypophysis, 
apart f rom a relatively small number of glial cells, which also express N C A M 
(Fig. 4-5), consists entirely of cell processes and terminals. Thus the membrane 
surface area is much larger on the basis of tissue weight in the latter compared to 
the former. 
Pancreatic tissue is characterized by the absence of N C A M staining of 
exocrine cells and the marked surface labeling of all endocrine cells of the islets 
of Langerhans, irrespective of the nature of their secretory products (Figs. 4-6 
and 4-7).Several years ago an N C A M related antigen was found to be present in 
rat testis localized on spermatids but not on mature spermatozoa (J0rgensen 
and M0l le r , 1983). Our recent preliminary studies on rat testis have also shown 
that groups of endocrine cells (Leydig cells) situated between the seminiferous 
tubules are immunoreactive wi th a n t i - N C A M sera. I n addit ion, marked 
extracellular staining was observed in this tissue. 
Molecular biological probes are currently being used to examine tissue 
distr ibution of the N C A M message. A major advantage of such techniques is 
their potential to study expression of individual exons in the transcript. Thus it 
is now possible to study not only the message for the major N C A M isoforms but 
also to detect the presence and analyze tissue distribution of the minor exons 
recently discovered. Using S I nuclease protection assays the presence of 
N C A M m R N A has been confirmed in adrenal gland, neuro- and adenohypo-
physis and pancreas (our unpublished results). 
4.3.6.2 N C A M Isoforms in Endocrine Tissues 
Immunochemical analysis of N C A M polypeptide profiles of brain and endo-
crine tissue extracts revealed unexpected differences (Fig. 4-8 and Langley et 
a l . , 1987, 1989a). Al though by immunocytochemistry w i t h polyclonal anti-
N C A M antibodies very similar cellular staining patterns are obtained wi th 
brain and endocrine tissues, the relative amounts of individual N C A M 
polypeptides in endocrine cells differ radically from those in brain: in addition 
one major exception was found amongst the endocrine tissues studied. N C A M 
156 4 Neural Cell Adhesion Molecule 
140 is the principal isoform expressed in rat adrenal gland, adenohypophysis 
and pancreatic islets but N C A M 180 is predominant in neurohypophysis. 
Cultured bovine adrenal medullary chromaffin cells may express measurable 
amounts of N C A M 180 (our own unpublished results; see also Nybroe et a l . , 
1986) but this could be due to the increased tendency of such cells to express a 
neuronal phenotype, as illustrated by the appearance of neurofilament proteins 
in cultured chromaffin cells though these are undetectable in vivo (Grant et a l . , 
1988). I n addit ion, this could also be the result of species differences in the 
expression of N C A M 180 by endocrine cells. Few data exist at the moment on 
interspecies N C A M polypeptide expression in endocrine cells. Analysis of 
human tissues indicate that N C A M 140 is the predominant form present in 
adenohypophysis and endocrine lung tumors (Aletsee-Ufrecht et a l . , 
1990b). 
The neurohypophysis appears to represent an exception to the idea that the 
endocrine N C A M phenotype is N C A M 140. A l l three major N C A M polypep-
tides are found in this tissue although N C A M 120 is a minor constituent. The 
fact that the cell processes that form the bulk of this organ derive from 
perikarya situated in paraventricular and supraoptic nuclei of the hypothala-
mus, thus sharing similar embryonic origins wi th other central nervous system 
Fig. 4-8 Immunoblots showing NCAM isoforms in cerebellum ( I ) , neurohypophysis 
(2), adenohypophysis (3), adrenal medulla (4). rat pheochromocytoma (5), pancreatic 
islets (6) and rat insulinoma cells (7). 
Extracts of rat tissues and cells were resolved by Polyacrylamide gel electrophoresis, 
transferred to nitrocellulose, and reacted with polyclonal anti-NCAM antibody. 
Immunoreactive bands were visualized with radiolabeled protein A and autoradiogra-
phy. Molecular masses (kD) are indicated (from Aletsee-Ufrecht et al.. 1988); by 
permission. 
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neurons, may be a sufficient reason to expect that their N C A M profile should 
more closely resemble that of CNS neurons. We have seen, however, that 
embryonic origin is not strictly determinant in N C A M expression.The structure 
of the neurohypophysis is quite different f rom that of other endocrine organs in 
that it is composed of cell processes that are very distant from their cell bodies. 
Studies on cultured neurones subjected to agents inducing neurite growth 
(Pollerberg et a l . , 1985, 1986) suggest that some compartmentalization of 
N C A M 180, perhaps due to an interaction w i t h the cytoskeleton (Pollerberg et 
a l . , 1987), may occur between cell body and cell processes, the concentration 
being greater on the latter. Thus the higher levels of N C A M 180 found in 
neurohypohysis may be the result of such compartmentalization. I n any case, 
these data show that all endocrine cells are not identical wi th regard to N C A M 
polypeptides, and that some may better suit the prefix "neuro-" in this context. 
I t is interesting to note that the N C A M . f o r m that persists in adult endocrine 
cells is the form that is reported to be first^expressed by very early embryos even 
before neural induction occurs (Levi et a l . , 1987; Jacobson and Rutishauser, 
1986) and that N C A M 180 is considered by some to be the more characteristic 
form of differentiated post-mitotic neurons (Polierberget a l . , 1985,1986). As is 
reviewed later, N C A M 140 is also the fo rm found in certain strictly non-neural 
cells. Endocrine cells may thus be viewed as expressing more primitive less 
characteristically neuronal N C A M forms. 
4.3.6.3 Endocrine Tumors 
The PC12 cell line, derived from a rat adrenal medullary pheochromocytoma, 
has provided neurobiologists wi th a useful model for studying both endocrine 
cell biology and neuronal differentiation and maturation. Since these cells also 
express N C A M , their response to nerve growth factor N G F in neurite 
outgrowth formation has also provided the opportunity of studying N C A M 
expression during such phenomenon. Conflict ing data have been published on 
the stimulatory effect of N G F (Doherty et a l . , 1988) or the absence of an effect 
(Friedlander et a l . , 1986) on certain forms of N C A M in PC12 cells. These 
differences may be the result of using different sublines of these cells. N C A M is 
essentially localized on the surface of PC12 cells as has been found for other 
endocrine and neural cells, and N C A M 140 is the predominant though not 
exclusive isoform present. Walsh's group observed both increased levels of 
N C A M 180 and N C A M m R N A of 7.2kb (the message considered to encode 
N C A M 180) after N G F treatment (Prentice et a l . , 1987), suggesting that this 
isoform may be more concentrated on neurite-like extensions. Elevated levels 
of this form have also been noted in another experimental endocrine tumor, a 
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Fig. 4-9 Cultured rat insulinoma (RIN A2) cells labeled for N C A M by immunofluo­
rescence. Note the pronounced surface labeling. Bar = 20 μπι. 
rat insulinoma (Fig. 4-9), compared wi th their normal counterparts (Langley et 
al . , 1987). Rat insulinoma cells in culture tend to produce thin cell process 
unlike normal pancreatic β cells although these are less pronounced than those 
of N G F treated PC12 cells.Thus increased N C A M 180 expression may not be a 
directly related to the malignant transformation, but associated wi th cell 
morphological changes. 
I t is interesting to note that the expression of another C A M first identified in 
PC12 as N G F inducible large external ( N I L E ) glycoprotein (McGuire et a l . , 
1978) and subsequently shown to be equivalent to the cell adhesion molecule 
N g C A M of chick (Friedlander et a l . , 1986) and L I in rodents (Bock et a l . , 1985) 
parallels that of N C A M 180 (Pigott and Kelly, 1986): it too is upregulated after 
N G F treatment. I n fact the expression of L I and N C A M 180 in many tissues is 
similar and may in part be due to an association between these two molecules 
(Thor et a l . , 1986) particularly on cell processes. Antibodies against L I have 
been found to strongly stain neurohypophysis (Langley et a l . , 1989b;), which 
also contain high levels of N C A M 180: in contrast adenohypophysis and 
pancreatic islets are weakly or not at all stained for L I nor do they contain 
N C A M 180. Chromaffin cells of the adrenal medulla represent an enigma, 
since only 20% appear to express L I strongly in the rat adrenal which contains 
very l i t t le N C A M 180. 
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Two main classes of human endocrine tumors have been recently studied wi th 
regard to their N C A M expression; lung tumors and hypophyseal tumors. We 
have studied the small cell lung carcinoma (SCLC) on cell lines established 
from several patients (Fig. 4-10, Aletsee-Ufrecht et a l . , 1990a).These cell lines 
grow best in suspension culture but can be grown on coverslips, facilitating 
immunocytochemistry, where they retain a rounded cell morphology and their 
endocrine phenotype as exemplified by the presence of synaptophysin and 
neuron specific enolase. Immunoblot analysis has shown that N C A M 140 is the 
predominant i f not exclusive N C A M form expressed. Other lung tumors 
examined included mesotheliomas, squamous cell carcinomas ( i . e. non-
endocrine tumors) and "large cell carcinoma". N C A M was found only in the 
latter: i t is l ikely that these tumors are derived from SCLC. N C A M levels were 
found to vary between different SCLC patients, and even between two lines 
derived from tumors of the same patient at different times. Levels of other cell 
markers were also found to vary but in different directions. I t can be concluded 
that the regulation of N C A M synthesis varies during the course of the disease 
and that such regulation parallels neither that of vesicle or souble proteins. 
We have also recently examined human pituitary tumors for the presence of 
N C A M (Aletsee-Ufrecht et al . , 1990b) including prolactinomas, growth 
hormone producing adenomas, and inactive adenomas, which were each 
characterized on the basis of clinical features, immunohistochemical data or 
Fig. 4-10 Cultured human small cell lung carcinoma (SCLC) cells immunofluorescently 
labeled for NCAM showing marked surface labeling. Bar = 20 μπι. 
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Fig. 4-11 Electron micrograph of human growth hormone producing adenoma immu-
nostained for NCAM, illustrating the intense surface labeling of these cells. Section not 
counterstained. Bar = 1 μηι (from Aletsee-Ufrecht et al.. 1990b, by permission of 
Elsevier, Amsterdam). 
serum hormone analyses. N C A M 140 was detectable on immunoblots of all but 
prolactinomas. Highly sensitive immunocytochemical methods confirmed a 
surface localization of N C A M in all these tumors (Fig. 4-11) even in 
prolactinomas, although staining intensity was much less in prolactinomas, 
confirming reduced levels in this tumor. 
The presence of N C A M in certain human tumors may also be responsible for 
the staining observed w i t h other anti-tumor antibodies of previously undeter­
mined antigen specificity. From a number of monoclonal antibodies developed 
against a variety of tumors, some have been shown to recognize the N C A M 
molecule (Patel et a l . , 1989). I n addition the staining of tumors wi th anti 
H N K - 1 (Leu7) antibodies (chapter 7; Wil l ison et a l . , 1986) could be due to a 
subset of N C A M molecules carrying the H N K - 1 carbohydrate hapten. 
4.3.7 Fibroblasts 
Fibroblasts represent a further ambiguous class of cells on which apparently 
contradictory data have been published. Earlier reports produced no evidence 
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of N C A M in fibroblasts. Fibroblasts in normal peripheral nerve in endo-, peri-
and epineural situations are N C A M negative in adult tissue and also at all 
developmental ages studied (Seilheimer and Schachner, 1988; Mar t in i and 
Schachner, 1988; Seilheimer et a l . , 1989). Fibroblasts isolated from skin and 
brain have not been found to contain N C A M . I n contrast, immunocytochem-
istry demonstrates N C A M expression by fibroblast-like cells which accumulate 
in nerve stumps after crush lesions or section of peripheral nerves and by 
perisynaptic fibroblasts in denervated muscle (Gatchalian et a l . , 1989). 
Fibroblasts isolated from both peripheral nerve and skeletal muscle and 
subsequently maintained in culture also have the capacity to express N C A M 
(Gatchalian et a l . , 1989). The isoform expressed is N C A M 140, which is the 
same as that found in peripheral nerve Schwann cells. Mesenchymal cells 
possibly related to fibroblasts in regenerating newt limbs have also been found 
to be N C A M positive (Maier et a l . , 1986).The capacity to express N C A M may 
thus be confined to particular subsets of fibroblasts or be induced either in 
culture or in pathological situations in which increased N C A M synthesis is 
known to occur: N G F activity also increases in peripheral nerves after 
injury. 
4.3.8 Muscle 
The considerable number of studies devoted to both adult and developing 
skeletal muscle since the ini t ial discovery of N C A M in embryonic muscle 
(Grumet et a l . , 1982) have provided valuable insight into the regulation of 
N C A M synthesis and its molecular biology. We wi l l not deal in detail here wi th 
muscle and the reader is referred to a recent review (Walsh, 1988) for a more 
detailed analysis. A brief discussion however of N C A M in muscle is pertinent in 
the context of its potential as a neural cell marker. I t was the first tissue outside 
the nervous system in which N C A M expression was found to persist into 
adulthood. While N C A M is detectable in all primit ive germ cell layers in early 
embryos, defined tissue inductive events lead either to its suppression or to its 
continued expression (Edelman, 1984). Dur ing skeletal muscle histogenesis, 
down-regulation of N C A M during myotube maturation and innervation is 
associated wi th a dramatic change in its localization on the surface membrane 
of the muscle cell. The wide distribution over the entire myotube surface is 
replaced in the adult by restricted expression over specialized contact regions, 
the neuromuscular junctions. This adult topographical distribution can be 
reversed to that found in immature muscle by denervation. 
Analysis of the polypeptide nature of muscle N C A M illustrates how different 
tissues can process these molecules in specific ways. In i t ia l immunoblot studies 
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on muscle suggested a molecular mass for this antigen similar to that of brain 
N C A M 140. Further investigations showed that muscle N C A M m R N A 
contains an additional exon, not present in brain, encoding an amino acid 
sequence unique to muscle, and it was suggested that the isoform present in 
differentiated myotubes is equivalent to a modified N C A M 120, which, like this 
brain isoform, is anchored to the plasma membrane by phosphatidyl inositol 
(Moore et a l . , 1987). 
4.3.9 Other Non-Neural Tissues 
A rare but unusually malignant kidney tumor (Wilms tumor) represents a 
particularly interesting example of N C A M re-expression in pathological tissue. 
N C A M is detectable during early development of the kidney, but it is 
subsequently down-regulated and is absent f rom the adult gland (Roth et a l . , 
1987). I n Wilms tumour N C A M has been found to be not only strongly 
expressed, but as the highly sialylated "embryonic" form (Roth et a l . , 1988). 
The malignant transformation may thus be interpreted in terms of a reversion 
of the normal differentiation and maturation process leading to a cell wi th more 
primitive characteristics. Elevated levels of high PSA containing N C A M 
undoubtedly influences the contact relationships and "social behaviour" of 
these cells, properties which many years ago had been suggested to be l inked to 
cell surface sialic acid content (Langley and Ambrose, 1964). 
N C A M has been detectable in a few other non-neural tissues. Several 
adhesion molecules have been fond in rodent intestine wi th different distribu-
tions (Thor et al . , 1986). N C A M appears to be confined to mesenchymal and 
neuroectodermal^ derived parts of the intestine. I n particular it was found to 
be located in the outer muscle layers, not only in Auerbachs plexus but also in 
mesenchymal parts, and it was present in the submucosa, the muscularis 
mucosa, the lamina propria surrounding the crypts and in the inner part of v i l l i . 
Surprisingly, all three N C A M isoforms were reported to be present, thus 
reflecting the CNS pattern rather than that found in peripheral nervous or 
non-nervous tissues. Individual N C A M containing cellular elements were 
unfortunately not identified in this study. Thus it is not known if intestinal 
endocrine cells contain N C A M . Some staining in the muscularis mucosa and in 
the lamina propria may be due to neurons or their processes. 
Chicken skin has been found to contain N C A M (Chuong and Edelman, 
1985a,b) which is similar or identical to that of brain except in its polypeptide 
profile: only N C A M 140 is detectable in skin (Murray et a l . , 1986).This persists 
into adulthood and is subject to the embryonic-adult post-translation modif i -
cation described for the brain antigen. I t is associated wi th the morphogenesis 
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of chicken feathers, a process which continues throughout adult l ife. A cyclic 
pattern of both N C A M and L C A M (equivalent to the calcium dependent cell 
adhesion molecule E-cadherin) expression is found in growing and regenerat-
ing feather buds. I n addition to membrane expression, N C A M is also located in 
certain extracellular regions after cell disappearance. N C A M m R N A has also 
been detected by the blot hybridization technique in embryonic heart, breast 
muscle, gizzard, lung and kidney (Murray et a l . , 1986). I n non-neural tissues 
N C A M 180 m R N A has been only detectable in association w i t h nervous 
elements such as the nerve plexuses in developing lung and the large enteric 
ganglia of gizzard. Most data suggest that when N C A M is present in non-neural 
tissues N C A M 140 is the isoform generally found. 
4.4 Expression of NCAM During Development 
Attempts to relate N C A M function to tissue structure and in particular to tissue 
inductive events have strongly motivated studies of its expression throughout 
embryonic development. Major "decisions" which determine the course of 
histogenesis are made relatively early in embryonic life. Radical changes in 
tissue levels of cell adhesion molecules which either stabilize intercellular 
contacts or promote cellular migration may be expected to coincide w i t h this 
period of intense activity of cell sorting and reorganisation. The pattern of 
N C A M expression is indeed extremely plastic during early embryonic life 
(Edelman, 1983, 1984b). This is also true in adult tissues subject to inductive 
changes (Chuong and Edelman, 1985a,b). I t is beyond the scope of this chapter 
to review in detail such complex changes in N C A M regulation during nervous 
tissue and endocrine tissue development. Readers are referred to the excellent 
studies by Edelmann group. In pioneering studiesThiery and coworkers (1982) 
reported the very early appearance of N C A M in embryonic tissues. N C A M is 
detectable in all three primitive germ layers, the endoderm, the mesoderm and 
the ectoderm, and has been shown to be present in those regions concerned 
with primary developmental axes (neural plate, neural tube, notochord, 
somites) and in those regions in which later inductive events occur such as the 
neural crest, optic, otic and pharyngeal placodes, cardiac mesoderm, meso-
nephric pr imordium and l imb buds. When tissue inductive events occur, N C A M 
expression may be either suppressed permanently or temporarily or maintained 
according to the nature of induction. 
A number of studies have addressed the problem of changing levels of 
N C A M during nervous tissue development. Levels vary between different 
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brain regions or tissues during development (Bock et a l . , 1983; Linnemann et 
al . , 1985). Levels are reduced more in myelinated tracts than in regions 
containing cell bodies (Dani loff et a l . , 1986b). Cerebellar development is a 
relatively late event compared wi th rat forebrain, occurring during the first 
three weeks of postnatal life. N C A M levels are low before bi r th but increase 
dramatically during the period of parallel fibre (granule cell axon) formation 
and synaptogenesis corresponding to a period of dramatic increase of neuronal 
surface area (J0rgensen and Honegger, 1983). Cerebellar N C A M subsequently 
decreases to a fairly constant level. This may be correlated wi th data from 
biosynthetic studies on cultures of rat brain cells obtained at embryonic day 17 
and at postnatal day 25, which demonstrate a 50 % reduction in overall level 
(Nybroe et a l . , 1986). Analysis of N C A M m R N A levels show that the levels of 
the transcription product are reduced during brain development three times 
more than that of the translation products (Gennarini et a l . , 1986).This may be 
interpreted in terms of a slower N C A M turnover as development proceeds or a 
higher N C A M m R N A stabilization. A slower turnover rate of N C A M has been 
suggested after insertion into plasma membranes after axonal transport in the 
optic system (Garner et a l . , 1986). Interestingly, even wi th in the cerebellum a 
differential distribution of individual N C A M polypeptides has been found 
during development (Pollerberg et a l . , 1985). While N C A M is detectable by 
immunocytochemistry wi th polyclonal antibodies recognizing all N C A M 
polypeptides at earliest times in the germinative layer of the cerebellum. 
N C A M 180 is not detectable in this zone. This polypeptide appears to be 
confined, in the molecular layer, to post-mitotic neurons. Regional differences 
have also been noted using specific probes capable of distinguishing between 
N C A M 180 and N C A M 140 messages (Murray et a l . , 1986). The N C A M 180 
message has been detected as early as the third day of embryonic life in chick 
spinal cord but was not found in neuroepithelium. Al though N C A M 140 
message was detectable in embryonic heart, breast-muscle, skin, gizzard lung 
and kidney, N C A M 180 m R N A was found to be absent from these tissues and 
only detectable in tissues containing neural elements (such as the large enteric 
ganglia in gizzard or the nerve plexuses in oesophagus and lung buds). Very 
recent in situ hybridization studies confirm these earlier findings (Pricto et a l . , 
1989). 
A particularly relevant example of developmental N C A M up- and down-
regulation in the context of this chapter is found in cells which constitute the 
adrenal medulla. The endocrine chromaffin cells are derived, as are sympa-
thetic ganglia, from N C A M positive precursors in the neural crest (Thiery et 
al . , 1982). When these cells migrate away from the neural crest towards their 
future site N C A M expression is suppressed. A t the same time substrate 
adhesion molecules are upregulated (Duband et a l . , 1986).The reaggregation 
of these cells during the histogenesis of the adrenal gland coincides wi th 
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renewed expression of N C A M 140, and is accompanied by down-regulation of 
fibronectin receptors. These data have been interpreted in terms of the 
stabilizing effect of N C A M on intercellular contacts, which would be counter-
productive during the migration phase, but which are critical during formation 
of the adrenal medulla. I n addition, since the cortical cells surrounding the 
centrally situated groups of adrenal medullary chromaffin cells do not express 
N C A M , a mechanism of "cell sorting" may operate in defining the particular 
tissue architecture of this endocrine gland (see Friedlander et a l . , 1989). 
4.5 Post-Translational Developmental 
Modifications 
The dramatic modifications in the expression of N C A M that occur during 
development or in post-traumatic or pathological situations underlined earlier 
can take a number of different forms. We have seen that tissue levels of total 
N C A M , and accordingly membrane density, is dependant on endogenous 
environmental s t imuli . Such factors may also differentially influence the 
transcription of individual m R N A species coding for the different N C A M 
isoforms independently of each other. I t is not yet known i f these various 
N C A M m R N A s differ in stability or translation efficiency. I n addition 
post-translational modifications represent a major aspect of these glycopro-
teins. N C A M is both phosphorylated and sulfated in its transit through the 
Golgi apparatus (Lyles et a l . , 1984b). No significant alterations in phosphory-
lation are thought to accompany nervous tissue development, and it would 
appear that they are unlikely to have major functional significance. Moreover, 
activators of protein kinase C, which is involved in the phosphorylation of many 
proteins, stimulates the synthesis of certain members of the immunoglobulin 
supergenc family but do not modify N C A M synthesis (Doherty et a l . , 1988). I n 
contrast the level of sulfation decreases during development (Lyles et a l . , 
1984b; Linnemann et al . , 1985). 
The post-translational modification which has received most attention 
concerns glycosylation. Expression of the H N K - 1 carbohydrate epitope and 
more recently another carbohydrate epitope called L3 have been studied 
(Kruse et a l . , 1984, 1985; Kei lhaueret a l . , 1985; K ü c h e r e r e t a l . , 1987) but the 
degree of sialylation of N C A M has been investigated in most detail. From a 
functional viewpoint, since the sialic acid content profoundly affects the 
adhesive binding capacity of N C A M , such modifications assume as much 
importance as N C A M membrane density. Sialylation of N C A M is unusual in as 
far as forms of N C A M wi th high sialic acid levels (as much as 30% of the 
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molecule) contain this sugar in the form of the a-2,8 polysialic acid (PSA, 
Cunningham et al . , 1983; Finne et a l . , 1983). A t the very earliest stages of 
embryonic development PSA levels appear to be low. Then N C A M with high 
PSA content is produced, and subsequently PSA content is reduced as 
development proceeds but certain zones wi th high PSA N C A M persist in the 
adult (Sunshine et a l . , 1987; Aaron and Chesselet, 1989; Rougon et al . , 1990). 
Since the appearance of the three principal N C A M isoforms is not simultaneous 
during development ( N C A M 120 appears somewhat later than the other two) it 
is not clear i f all forms are poly-sialylated to the same degree. Data f rom 
explant cultures of mouse and chick tissues suggest that the conversion from 
high to low PSA N C A M is not due to processing of the embryonic in to the adult 
fo rm, but by de novo synthesis of N C A M wi th lower sialic acid content and that 
this is due to intracellular regulation of sialyl transferase (Friedlander et a l . , 
1985). More recently (Breen et al . , 1987,1988) found that an endogenous Golgi 
sialytransferase was capable of sialylating N C A M 180 and N C A M 120 in situ, 
though curiously obtained no evidence of N C A M 140 sialylation under their 
conditions. I n addition highest tissue activities of this enzyme coincide w i t h 
highest tissue levels of N C A M PSA. 
I n pathological tissues increased PSA N C A M levels (Dani loff et a l . , 1986a) 
has been linked to the process of cellular reorganisation. I n contrast in 
developing cerebellum no correlation was found between reduction in PSA 
levels and the migratory status of cerebellar granule neurons (Nagata and 
Schachner, 1986). 
A t present no direct data exist on N C A M sialylation in neuroendocrine 
tissues. I n the adult it is likely to be relatively low since immunoblots reveal the 
presence of discrete N C A M bands. Some data suggest that in the neurohypo-
physis PSA levels may be higher (Langley et a l . , 1989a). 
4.6 Concluding Remarks on NCAM as a 
Neuronal and Neuroendocrine Cell Marker 
The original concept that N C A M is confined in the adult to neurons and 
moreover wi th restricted localization to specialized regions of the neuronal 
membrane has been gradually eroded over the past few years. Clearcut 
evidence has demonstrated its expression by other neural cells in both PNS and 
CNS and also by endocrine cells independant of whether their embryological 
origin is neuroectodermal or not. I n addition the presence of N C A M in adult 
muscle and certain other non-nervous tissues of adult chicken including skin 
and lung confirms the wider than neural distribution of this molecule. The 
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cellular expression of N C A M cannot thus be taken as an absolute criterion of 
neuronal character. N C A M 140 may be regarded as the more typical isoform of 
neuroendocrine cells and may provide an additional parameter to characterize 
putat ive neuroendocrine cells in non-nervous tissues. For example the 
expression of N C A M 140 by SCLC contrasts wi th its absence in other lung 
tumors such as mesotheliomas or adenomas, confirming the endocrine nature 
o f this tumor. 
I n contrast N C A M 180 appears to be more characteristic of post-mitotic 
mature neurones than of other neural cells in their terminally differentiated 
state. Strictly non-neural cells do not appear to express this isoform, although 
the capacity of paraneurons to synthesize N C A M 180 does not seem to be 
permanently lost. As has been shown for pheochromocytoma PC12 cells, 
s t imul i which predispose differentiation towards a neuronal phenotype may 
up-regulate synthesis of N C A M 180. I n quantitative terms, however, the 
expression of N C A M is heavily biased towards the nervous system. Levels 
found even in neural crest-derived tissues are much lower than those of the 
CNS. I n addi t ion, levels of N C A M have been found to vary between different 
types of endocrine tumor. For instance, human prolactinomas appear to 
contain less than growth hormone producing or inactive adenomas of the 
hypophysis. This may itself be of use to distinguish between tumors particularly 
i f the prolactinoma is inactive. 
Nevertheless it is clear that the use of N C A M as a marker lo r neural and 
neuroendocrine cells should be treated w i t h caution. No single marker protein 
fulfil ls the cri terion of absolute specificity. Together wi th a battery of other 
marker proteins N C A M isoforms can aid cellular characterization and 
diagnosis of tumors. Polysialylation of N C A M polypeptides represents an 
unusual post-translational modification probably unique to members of this 
family of proteins. Its reappearance or continued presence in adult tissues 
seems to be associated wi th either altered intercellular contact phenomena 
fo l lowing a pathological process or wi th the need to retain a higher degree of 
plasticity in cell contacts in normal tissues. Its presence in Wilms tumor suggests 
it would be a good marker in this tissue and prompts its search in other tumors. 
A recent report (Moolenaar et a l . , 1990) showed the presence of high levels of 
N C A M sialylation in a cell line derived from an endocrine lung tumor. I t is 
possible that high PSA N C A M forms may be generally associated wi th the 
dedifferentiated state of malignantly transformed neural and neuroendocrine 
cells. 
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